Abliva

BIO-Europe Spring Digital
2023-03-20 - 2023-03-22 | Virtual
We will digitally attend this year’s BIO-Europe spring, hosted in Basel, Switzerland, on March 20 – 22, 2023.
This major life science and biotech meeting offers a great opportunity for networking and partnering.

Kempen Life Science Conference
2023-04-25 - 2023-04-26 | Van Lanschot Kempen, Beethovenstraat 300, Amsterdam, 1077 WZ
In April, we will attend this year’s Kempen Life Science Conference in Amsterdam, Netherlands.

Bio€quity Europe 2023
2023-05-14 - 2023-05-16
In mid-May, Abliva will attend and present at Bio€quity Europe 2023 in Dublin, Ireland.
“For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner and debate critical issues facing the biotech industry today.”
CEO Ellen Donnelly will present the company on May 15 during the session Other Approaches in Orphan Diseases, at 14:07 GMT.

Penser Market Bolagsdag
2023-05-25 09:00 - 17:00 (Europe/Stockholm) | Haymarket by Scandic, Hötorget 13-15, Stockholm, 11157, Sweden
On May 25, Abliva will participate at Erik Penser Bank’s Penser Market Bolagsdag in Stockholm.
Abliva’s CMO, Magnus Hansson, will be presenting the company during the morning session.
Further details and link to event below.

ABG Sundal Collier's Life Science Summit Seminar
2023-05-30 - 2023-05-31 | ABG Sundal Collier, Regeringsgatan 25, Stockholm, Sweden
In late May, Abliva will attend and present at ABG Sundal Collier’s Life Science Summit Seminar in Stockholm, Sweden.
The event will also be live-streamed. See below for more info.

BIO International Convention
2023-06-05 - 2023-06-08 | Boston Convention & Exhibition Center, Boston, MA, United States
In early June, Abliva will attend the BIO International Convention in Boston, US.

Euromit 2023
2023-06-11 - 2023-06-15 | Bologna Congress Center, Piazza della Costituzione, 4/a, Bologna, Italy
In June, Abliva will attend this year’s edition of Euromit – the international conference on mitochondrial disease.
The meeting takes place in Bologna, Italy, and gathers researchers, clinicians, and patients for the sharing of knowledge and insights in the field. The conference also presents opportunities to meet with investigators in our FALCON study with KL1333.

UMDF’s Mitochondrial Medicine Symposium 2023
2023-06-28 - 2023-07-01 | Sheraton Charlotte Hotel/Le Méridien, 555 SOUTH MCDOWELL STREET, Charlotte, NC, 28204, United States
In late June, Abliva will be attending this year’s international Mitochondrial Medicine Symposium, organized by US patient organization United Mitochondrial Disease Foundation.
The meeting will take place in Charlotte, North Carolina (US), on June 28 – July 1, and includes both scientific as well as patient and family sessions.

The Future of Swedish & Danish Life Science
2023-09-07 | Restaurant Inspira, Scheelevägen 4, Lund, 22363, Sweden
Abliva will participate at the 12th annual edition of ‘The Future of Swedish & Danish Life Science’, on September 7, 2023, in Lund, Sweden.
The company’s Chief Medical Officer, Magnus Hansson, will give a talk entitled Pivotal study design in a rare disease with no regulatory precedent – utilizing patient advocacy groups and registries.
“The Future of Swedish & Danish Life Science offers a dynamic full-day experience with highly relevant seminars, networking and partnering meetings, as well as a lively exhibition. The event annually draws around 500 influential decision-makers representing the pharma, biotech and medtech sectors as well as academia, healthcare, policy makers, regulatory authorities, and financial services.”
Follow the link below for more details.

LSX World Congress USA
2023-09-13 - 2023-09-14 | Hynes Convention Centre, Boston, MA, United States
In September, Abliva will attend the LSX World Congress USA, in Boston, MA.
The event gathers North America’s leading Biotech, Medtech and Healthtech CEOs along with investors, big pharma, and advisors.

Penser South Company Day
2023-09-14 | Malmö, Malmö, Sweden
Our Chief Medical Officer, Magus Hansson, will give a talk at Penser South Company Day in Malmö, on September 14, 2023.
Click the link below for more details and registration.

Empower & Inspire - 2nd Annual Leigh Syndrome Symposium
2023-09-19 | Virtual
During World Mitochondrial Disease Week, Abliva’s Chief Medical Officer, Magnus Hansson, will present the company at the Cure Mito Foundation’s Empower & Inspire – 2nd Annual Leigh Syndrome Symposium (virtual).
See below for more information and the link to the event.

BioStock Life Science Summit 2023
2023-10-25 - 2023-10-26 | Medicon Village, Scheeletorget 1, Lund, Sweden
In late October, Abliva will attend the BioStock’s Life Science Summit at Medicon Village in Lund.
Magnus Hansson, Abliva’s Chief Medical Officer, will be presenting the company at 09:05 a.m. CET on October 25.
See more details and the link to the event below.

Hadean Venture's Annual Event
2023-10-25 - 2023-10-26 | Oslo, Norway
In October, Abliva’s CEO, Ellen Donnelly, will attend Hadean Venture’s annual event in Oslo.

LSX Inv€$tival Showcase and Jefferies London Healthcare Conference
2023-11-13 - 2023-11-16 | London, London
This fall, Abliva’s CEO, Ellen Donnelly will attend the two connected events LSX Inv€$tival Showcase and Jefferies London Healthcare Conference.
On November 13 at 11:45 a.m., the Abliva’s CEO, Ellen Donnelly, will present the company at LSX Inv€$tival Showcase.
See the link below for more details.

Nordic Life Science Days
2023-11-29 - 2023-11-30 | Bella Center, Center Boulevard 9, Copenhagen, 2300, Denmark
In late November, Abliva will attend Nordic Life Science Days, at Bella Center in Copenhagen, Denmark.
CEO Ellen Donnelly will be presenting the company during the session Biotechnology – Therapeutics & Diagnostics on November 29 at 2:12 p.m. CET in Auditorium 10.
Follow the link below for more details.

J.P. Morgan Healthcare Conference
2024-01-08 - 2024-01-11 | San Francisco, San Francisco, United States
In early January 2024, Abliva’s CEO, Ellen Donnelly, will attend the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, USA.
The conference is a healthcare investment symposium that connects global industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
Follow the link below to learn more.

Mitochondrial Medicine - Therapeutic Development
2024-03-18 - 2024-03-20
In mid-March, Abliva will attend the 8th edition of Mitochondrial Medicine – Therapeutic Development in Hinxton, UK.
This annual scientific meeting is focused on mitochondrial disorders and the search for novel effective therapies.
Abliva’s CMO, Maguns Hansson, will join the panel discussion Challenges and opportunities in clinical trials: perspectives
from pharma and funders, where representatives from other companies in the field as well as academic and clinical experts also participate.
Follow the link below to learn more.

Kempen Life Sciences Conference
2024-04-16 - 2024-04-17
In mid-April, Abliva will participate at Kempen Life Sciences Conference in Amsterdam, The Netherlands.
For more information, please click the link below.

Bio€quity Europe
2024-05-12 - 2024-05-14 | Kursaal Elkargunea Center, Zurriola Hiribidea, 1, San Sebastián, 20002, Spain
In mid-May, Abliva will travel to the Bio€quity Europe meeting in San Sebastán, Spain.
“For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner, and debate critical issues facing the biotech industry.”
Abliva’s CEO, Ellen Donnelly, will, together with the company’s CMO, Magnus Hansson, be networking and presenting the company during the event.
Follow the link below to learn more.

Virtual KOL event on KL1333
2024-05-21 16:00 - 17:00
Join Abliva for a virtual KOL event featuring Amel Karaa, MD (Massachusetts General Hospital), who will discuss the unmet medical need and current treatment landscape for patients with primary mitochondrial disease. There are currently no approved medicines for the systemic disease.
The event will focus on Abliva’s lead program, KL1333, which has shown clinically meaningful, early signals of efficacy in mitochondrial disease patients. This novel therapeutic approach modulates the underlying pathophysiology in mitochondrial disease. KL1333 is currently being evaluated in the pivotal Phase 2 FALCON trial, with interim analysis expected mid-year 2024. KL1333 has Orphan Drug Designation (ODD) in both Europe and the U.S. and Fast Track designation in the U.S.
Registration information
Register here: https://lifescievents.com/event/abliva/
A live question and answer session will follow the formal presentation. Ask your question to: questions@lifesciadvisors.com.
You are required to register in advance for the webcast. For those who are unable to attend live, a replay will be available via the link below.

BIO International
2024-06-03 - 2024-06-06 | San Diego, San Diego, CA, United States
In early June, Abliva’s CEO, Ellen Donnelly, travels to San Diego to attend BIO International 2024.
Follow the link below for more information.

Mito Med 2024
2024-06-26 - 2024-06-29 | Cleveland, Ohio, Cleveland, OH, United States
In late June, Abliva will attend the US patient organization UMDF’s Mitochondrial Medicine Conference in Cleveland, Ohio.
“Each year, UMDF’s Mitochondrial Medicine Conference brings together the best minds in mitochondrial medicine and the patients we serve. With over 700 attendees representing almost every state in the U.S. and more than 15 different countries, the Conference is recognized as the world’s preeminent event for mitochondrial disease.”
Click the link below for more information.

Nordic Life Science Days
2024-09-18 - 2024-09-19 | Malmömässan, Mässgatan 6, Malmö, 215 32, Sweden
In September, Abliva will attend the Nordic Life Science Days (NLS days) in Malmö, Sweden.
Ablia’s CEO, Ellen Donnelly, will be presenting the company at 11:00 a.m. CET on September 18, in the session Biotechnology.
Follow the link below for more information.

Mitocon's Mitochondrial Disease Conference
2024-10-25 - 2024-10-27 | BW Plus Hotel Galileo, Via Venezia 30, Padova, Italy
In late October, Abliva will attend the 14th Mitochondrial Disease Conference, this year in Padua (IT), organized by the Italian patient organization Mitocon.
Abliva’s CMO, Magnus Hansson will attend the session: Roundtable with Pharmaceutical Industries and Regulatory Authorities.
Read more by following the link below.

BIO-Europe
2024-11-04 - 2024-11-06 | Stockholm, Stockholm, Sweden
In early November, Abliva’s CEO, Ellen Donnelly, will attend the BIO-Europe meeting in Stockholm, Sweden.
On Monday, November 4, Ellen will be presenting the company at 4:30 p.m. CET.
Follow the link below for further details.

CNS Summit 2024
2024-11-10 - 2024-11-13 | Encore Boston Harbor, Boston, MA, United States
Abliva will attend the CNS Summit 2024, taking place November 10-13 at Encore Boston Harbor.
The company’s CEO, Ellen Donnelly, has organized and will join the spotlight panel discussion: Medicines for Mito: Developing Medicines for Mitochondrial Dysfunction Spotlight Session, on November 11, at 1:00 p.m. ET, featuring representatives from Stealth-, Tisento- and Saol Therapeutics.
Follow the link below for further details.

Investival Showcase
2024-11-18 | Tobacco Dock, Wapping Lane, London, E1W 2SF, United Kingdom
In mid-November, Abliva will attend LSX’s Investival Showcase in London, UK.
Abliva’s CEO, Ellen Donnelly, will be presenting the company at 11:30 a.m. GMT.
The Investival Showcase is a Biotech, Healthtech, and Medtech Networking & Pitching Event.
Follow the link below for more details.

BioStock Life Science Summit
2024-11-19 - 2024-11-21 | Medicon Village, Scheeletorget 1, Lund, Sweden
In late November, Abliva will participate in BioStock’s Life Science Summit in Lund, Sweden.
CMO, Magnus Hansson, will be presenting the company at 15:10 CET on November 21.
For more details on the event, follow the link below.
